Justices Told Thyroid Drug Patent Ax Flouts Global Pact

By Tiffany Hu (March 8, 2021, 10:09 PM EST) -- The U.S. Supreme Court was urged to overturn a Federal Circuit ruling that a patent on the thyroid drug Tirosint is invalid as indefinite, with the patent owner arguing that the decision "flatly contradicts" an international agreement that foreign and U.S. inventors be treated equally....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!